期刊文献+

复方丹参滴丸联合西药对老年冠心病患者的治疗效果 被引量:3

Efficacy of compound danshen dripping pills combined with western medicine on senile patients with coronary heart disease
原文传递
导出
摘要 目的 探讨复方丹参滴丸联合西药治疗老年冠心痛的效果.方法 随机选取2012年8月至2014年8月老年冠心病患者70例,依据治疗药物分为两组,每组35例.对照组予以阿司匹林治疗,观察组在对照组基础上予以复方丹参滴丸治疗,比较两组疗效.结果 观察组治疗有效率91.43%高于对照组71.43%,差异有统计学意义(P<0.05);观察组治疗后NO为(81.26±7.85) μmol/L高于对照组,ET-1为(69.22±6.97) pg/ml低于对照组,差异有统计学意义(P<0.05).结论 复方丹参滴丸联合西药能够改善老年冠心痛患者血管内皮功能,提高临床疗效. Objective To investigate the effect of compound danshen dripping pills combined with western medicine on senile patients with coronary heart disease.Methods From August 2012 to August 2014, 70 senile patients with coronary heart disease were randomly selected, and divided into two groups according to therapeutic drug, with 35 cases in each group.The control group received aspirin, while the observation group was combined with danshen dripping pills.The effects of the two groups were compared.Results The effective rate in the observation group was 91.43 % , which was higher than that in the control group(71.43%), the difference was significant (P 〈 0.05);NO of the observation group after treatment was (81.26 ± 7.85) mmol/L, which was higher than that of the control group, ET-1 [(69.22 ± 6.97) pg/ml] was lower than that of the control group, the differences were significant (P 〈 0.05).Conclusions Compound danshen dripping pills combined with western medicine can improve the vascular endothelial function of senile patients with coronary heart disease and improve the clinical efficacy.
出处 《中国实用医刊》 2015年第24期18-19,共2页 Chinese Journal of Practical Medicine
关键词 冠心病 复方丹参滴丸 血管内皮功能 Coronary heart disease Compound danshen dripping pills Vascular endothelial function
  • 相关文献

参考文献5

二级参考文献40

  • 1周俊,陆国平,戚文航.转录因子NF-κB对血管成形术后血管狭窄和新生内膜形成的影响[J].中国药理学通报,2005,21(10):1204-1209. 被引量:2
  • 2中国药典委员会.中国药典[s].北京:中国医药科技出版社,2010:80.
  • 3Allerod C,Rees SE, Rasmussen BS, et al. A decision sup- port system for suggesting ventilator settings:retrospec- tive evaluation in cardiac surgery patients ventilated in the ICU[J]. Comput Methods Programs Biomed, 2008, 92 (2) :205-212.
  • 4Cote GA, Rice JP, Bulsiewicz W, et al. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users[J]. Am J Gastroen- terol, 2008,103 ( 5 ) : 1097-1103.
  • 5Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cellproliferation and endothelial regeneration after vascular injury andstenting: approach to therapy[J]. Circ J, 2011, 75(6): 1287-96.
  • 6hang L, Lu H, Huang J, et al. Simvastatin exerts favourable effectson neointimal formation in a mouse model of vein graft[J]. Eur JVasc Endovasc Surg, 2011, 42(3): 393-9.
  • 7Ortolani P, Balducelli M, Marzaroli P, et al. Two-year clinicaloutcomes with drug-eluting stents for diabetic patients with de novocoronary lesions: results from a real-world multicenter registry[J].Circulation, 2008, 117(7): 923-30.
  • 8Kuwano T, Miura S, Shirai K, et al. Serum levels of bilirubin as anIndependent predictor of coronary in-stent restenosis: a new look atan old molecule[J]. J Atheroscler Thromb, 2011, 18(7): 574-83.
  • 9Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifyingenzyme A20 is required for termination of Toll-like receptorresponses[J]. Nat Immunol, 2004, 5(10): 1052-60.
  • 10Ginn-Pease ME, Whisler RL. Redox signals and NF-kappaBactivation in T cells[J]. Free Radic Biol Med, 1998, 25(3): 346-61.

共引文献137

同被引文献16

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部